Alphinity Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Alphinity Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,440,877	Closed	-$717M	–	37
2025 Q1	$717M	Buy	1,440,877 +164,324	+13%	+$89M	4.86%	8
2024 Q4	$664M	Buy	1,276,553 +26,197	+2%	+$14.4M	3.61%	14
2024 Q3	$773M	Buy	1,250,356 +937,050	+299%	+$555M	4.57%	12
2024 Q2	$173M	Buy	+313,306	New	+$179M	1.28%	21
2018 Q4	–	Sell	-75,525	Closed	-$18.4M	–	31
2018 Q3	$18.4M	Sell	75,525 -34,452	-31%	-$7.93M	3.51%	14
2018 Q2	$22.8M	Buy	109,977 +12,239	+13%	+$2.6M	4.62%	6
2018 Q1	$20.2M	Buy	97,738 +67,873	+227%	+$14.2M	4.58%	6
2017 Q4	$5.67M	Buy	+29,865	New	+$5.72M	5.09%	9

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alphinity Investment Management's TMO Position: Q2 2025 in Review

Alphinity Investment Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,440,877 shares — an estimated $717M sold.

Alphinity Investment Management first reported a position in TMO in Q4 2017 and held it in 8 quarters. The position peaked at $773M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Alphinity Investment Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Alphinity Investment Management sold 1,440,877 Thermo Fisher Scientific shares in Q2 2025, an estimated $717M.
Alphinity Investment Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 8 quarters.
Alphinity Investment Management's Thermo Fisher Scientific position peaked at $773M in Q3 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Alphinity Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.